Skip to main content
. 2021 Jun 18;23(6):941–951. doi: 10.1007/s11307-021-01621-0

Fig. 1.

Fig. 1.

(a) Ex vivo gamma counting of selected tissue biodistribution and (b) tumors of LS1034 mice (mean %ID/g ± SEM) at 22 h post 89Zr-Df-IAB22M2C injection on days 4 and 9 following initiation of BsAb treatment 0.03, 0.1, and 1 mpk for PF-07062119 (Tx) and 1 mpk for PF-07079699 non-targeted CD3 (Isotype) control treated.